Infusion of flesinoxan into the amygdala blocks the fear-potentiated startle

NeuroReport

Volumn 11, Issue 10, 2000, Pages 2285-2288

  Groenink, Lucianne ^a   Joordens, Rosemarie J E ^a   Hijzen, Theo H ^a   Dirks, Anneloes ^a   Olivier, Berend ^a,b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anxiety; Central nucleus of the amygdala; Dorsal raphe nucleus; Fear potentiated startle; Flesinoxan; 5 HT(1A) receptor; Median raphe nucleus; Rat

Indexed keywords

DRUG VEHICLE; FLESINOXAN; SEROTONIN 1A AGONIST;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; DOSE RESPONSE; DRUG EFFECT; FEAR; MALE; MEDIAN RAPHE NUCLEUS; NONHUMAN; PRIORITY JOURNAL; RAT; STARTLE REFLEX; TRANQUILIZING ACTIVITY;

EID: 0034647794     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-200007140-00043     Document Type: Article

References (25)

1. 1. Davis M, Falls WA, Campeau S et al. Behav Brain Res 58, 175-198 (1993).
2. 2. Hijzen TH, Houtzager SWJ, Joordens RJE et al. Psychopharmacology 118, 150-154 (1995).
3. 3. Schipper J, Tulp MThM, Berkelmans B et al. Human Psychopharmacol 6, S53-S61 (1991).
4. 4. Joordens RJE, Hijzen TH, Peeters BWMM et al. Psychopharmacology 126, 104-109 (1996).
5. 5. Kehne JH, Cassella JV and Davis M. Psychopharmacology 94, 8-13 (1988).
6. 6. Mansbach RS and Geyer MA. Eur J Pharmacol 156, 375-383 (1988).
7. 7. Joordens RJE, Hijzen TH and Olivier B. Psychopharmacology 139, 383-390 (1998).
8. 8. Griebel G. Pharmacol Ther 65, 319-395 (1995).
9. 9. Koch M. Prog Neurobiol 59, 107-128 (1999).
10. 10. Hitchcock J and Davis M. Behav Neurosci 100, 11-22 (1986).
11. 11. Pazos A and Palacios M. Brain Res 346, 205-230 (1985).
12. 12. Ohuoha DC, Hyde TM and Kleinman JE. Psychopharmacology 112, S5-S15 (1993).
13. 13. Parent A, Descarries C and Beaudet A. Neuroscience 6, 115-138 (1981).
14. 14. Matsuzaki S, Takada M, Li YQ et al. Neuroscience 55, 403-416 (1993).
15. 15. Vertes RP, Fortin WJ and Crane AM. J Comp Neurol 17 407, 555-82 (1999).
16. 16. Paxinos G and Watson C. The Rat Brain in Stereotaxic Coordinates. New York: Academic Press, 1982.
17. 17. Hijzen TH and Slangen JL. Psychopharmacology 99, 362-365 (1989).
18. 18. Davis M. Psychopharmacology 62, 1-7 (1979).
19. 19. De Vry J. Psychopharmacology 121, 1-26 (1995).
20. 20. Jolas T, Schreiber R, Laporte AM et al. J Pharmacol Exp Ther 272, 920-929 (1995).
21. 21. Davis M, Cassella JV and Kehne JH. Psychopharmacology 94, 14-20 (1988).
22. 22. Bosker FJ, Klompmakers AA, and Westenberg GM. Eur J Pharmacol 333, 147-157 (1997).
23. 23. Bosker FJ, Vrienten D, Klompmakers AA et al. Naunyn-Schmiedeberg's Arch Pharmacol 355, 347-353 (1997).
24. 24. Menard J and Treit D. Neurosci Biobehav Rev 23, 591-613 (1999).
25. 25. Hitchcock JM and Davis M. Behav Neurosci 105, 826-842 (1991).